血管生成素-话题@MedSci

#血管生成素#

17篇内容 | 719人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1666892, encodeId=793d16668922f, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle= Haemophilia：血友病患者中内皮糖蛋白水平升高与血管生成相关血管生成素 2 相关, objectType=article, longId=292727, objectId=073d292e2758, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=073d292e2758, replyNumber=0, likeNumber=52, createdTime=2022-05-16, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=073d292e2758, moduleTitle= Haemophilia：血友病患者中内皮糖蛋白水平升高与血管生成相关血管生成素 2 相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=073d292e2758)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666890, encodeId=62d3166689085, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Crit Care：血管生成素2在严重急性肾损伤预测效能上优于其他内皮生物标志物, objectType=article, longId=206910, objectId=fd8c20691044, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd8c20691044, replyNumber=0, likeNumber=45, createdTime=2021-09-09, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd8c20691044, moduleTitle=Crit Care：血管生成素2在严重急性肾损伤预测效能上优于其他内皮生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd8c20691044)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666891, encodeId=fb89166689141, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=BMC Gastroenterology：血管生成素2可以预测丙型肝炎患者的肝血管生成和纤维化程度, objectType=article, longId=207206, objectId=356520e20663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=356520e20663, replyNumber=0, likeNumber=29, createdTime=2021-03-23, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=356520e20663, moduleTitle=BMC Gastroenterology：血管生成素2可以预测丙型肝炎患者的肝血管生成和纤维化程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=356520e20663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666889, encodeId=1255166688981, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=GUT：许正平/盛静浩团队发现血管生成素可维持肠道菌群稳态阻止肠炎发生, objectType=article, longId=200194, objectId=56d3200194da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56d3200194da, replyNumber=0, likeNumber=0, createdTime=2020-10-31, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56d3200194da, moduleTitle=GUT：许正平/盛静浩团队发现血管生成素可维持肠道菌群稳态阻止肠炎发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56d3200194da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666887, encodeId=8973166688edb, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=JCEM：血清血管生成素样蛋白6与2型糖尿病风险, objectType=article, longId=189296, objectId=9a1118929684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a1118929684, replyNumber=0, likeNumber=30, createdTime=2020-04-15, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a1118929684, moduleTitle=JCEM：血清血管生成素样蛋白6与2型糖尿病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a1118929684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666888, encodeId=57a216668881a, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=JAK抑制剂Olumiant和抗血管生成素-2单抗LY3127804将用于新冠病毒COVID-19患者临床试验, objectType=article, longId=192249, objectId=f473192249cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f473192249cd, replyNumber=0, likeNumber=45, createdTime=2020-06-13, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f473192249cd, moduleTitle=JAK抑制剂Olumiant和抗血管生成素-2单抗LY3127804将用于新冠病毒COVID-19患者临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f473192249cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666886, encodeId=de56166688603, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Am J Transl Res：COMP-血管生成素-1对尿毒症腹膜透析大鼠腹膜血管通透性和腹膜转运功能的保护作用, objectType=article, longId=188915, objectId=e58818891561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e58818891561, replyNumber=0, likeNumber=32, createdTime=2020-03-04, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e58818891561, moduleTitle=Am J Transl Res：COMP-血管生成素-1对尿毒症腹膜透析大鼠腹膜血管通透性和腹膜转运功能的保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e58818891561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666885, encodeId=be9e1666885ea, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Hepatology：血管生成素2是CHC患者接受DAA治疗后，HCC复发或新发的重要预测因素, objectType=article, longId=149526, objectId=cefb1495267d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cefb1495267d, replyNumber=0, likeNumber=42, createdTime=2018-12-18, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cefb1495267d, moduleTitle=Hepatology：血管生成素2是CHC患者接受DAA治疗后，HCC复发或新发的重要预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cefb1495267d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666884, encodeId=c2bd166688498, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=JCEM：血管生成素样蛋白2促进糖尿病肾病的进展, objectType=article, longId=146941, objectId=1fd014694190, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fd014694190, replyNumber=0, likeNumber=24, createdTime=2018-10-19, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fd014694190, moduleTitle=JCEM：血管生成素样蛋白2促进糖尿病肾病的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fd014694190)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666883, encodeId=1a8c1666883bc, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Brit J Cancer：类血管生成素蛋白3能够阻断FAK的细胞核输入并有助于索拉非尼响应, objectType=article, longId=145659, objectId=d9b514565909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9b514565909, replyNumber=0, likeNumber=40, createdTime=2018-09-13, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9b514565909, moduleTitle=Brit J Cancer：类血管生成素蛋白3能够阻断FAK的细胞核输入并有助于索拉非尼响应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9b514565909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666880, encodeId=fb921666880e2, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子, objectType=article, longId=134584, objectId=a694134584fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a694134584fd, replyNumber=0, likeNumber=37, createdTime=2018-04-27, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a694134584fd, moduleTitle=Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a694134584fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666882, encodeId=d9c11666882f2, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Biomed Pharmacother：血管生成素2促进组织工程骨中的血管生成，并通过诱导自噬改善骨缺损的修复, objectType=article, longId=144883, objectId=e3811448835f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3811448835f, replyNumber=0, likeNumber=36, createdTime=2018-12-29, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3811448835f, moduleTitle=Biomed Pharmacother：血管生成素2促进组织工程骨中的血管生成，并通过诱导自噬改善骨缺损的修复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3811448835f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666881, encodeId=f69e16668813d, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Diabetologia：早孕期血管生成素样蛋白8可改善妊娠期糖尿病的预测, objectType=article, longId=134770, objectId=2eb7134e701f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eb7134e701f, replyNumber=0, likeNumber=39, createdTime=2018-12-24, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eb7134e701f, moduleTitle=Diabetologia：早孕期血管生成素样蛋白8可改善妊娠期糖尿病的预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eb7134e701f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666879, encodeId=9e4e16668e906, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=JCEM：血管生成素样蛋白3对血浆脂蛋白水平的影响, objectType=article, longId=103071, objectId=f7141030e169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7141030e169, replyNumber=0, likeNumber=45, createdTime=2018-01-15, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7141030e169, moduleTitle=JCEM：血管生成素样蛋白3对血浆脂蛋白水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7141030e169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666878, encodeId=03cd16668e894, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Nat Commun：阻断血管生成素的肿瘤治疗为何效果不一？, objectType=article, longId=46565, objectId=8de5465658f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8de5465658f, replyNumber=0, likeNumber=40, createdTime=2015-02-08, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8de5465658f, moduleTitle=Nat Commun：阻断血管生成素的肿瘤治疗为何效果不一？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8de5465658f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666877, encodeId=911d16668e732, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=Nat Rev Drug Discov：血管生成素抑制剂 trebananib三期临床失败, objectType=article, longId=43656, objectId=672943656a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=672943656a5, replyNumber=0, likeNumber=61, createdTime=2015-07-15, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=672943656a5, moduleTitle=Nat Rev Drug Discov：血管生成素抑制剂 trebananib三期临床失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=672943656a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666876, encodeId=708f16668e60e, content=<a href='/topic/show?id=93bc89e043b' target=_blank style='color:#2F92EE;'>#血管生成素#</a>, objectTitle=EHJ：循环血管生成素增加心源性休克病人死亡风险, objectType=article, longId=20374, objectId=45bd203e474, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45bd203e474, replyNumber=0, likeNumber=49, createdTime=2014-02-08, rootId=0, userName=xinmeili, userId=ff2526069317, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45bd203e474, moduleTitle=EHJ：循环血管生成素增加心源性休克病人死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45bd203e474)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血管生成素

2020-05-29

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Haemophilia：血友病患者中内皮糖蛋白水平升高与血管生成相关血管生成素 2 相关

2022-05-16

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Crit Care：血管生成素2在严重急性肾损伤预测效能上优于其他内皮生物标志物

2021-09-09

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

BMC Gastroenterology：血管生成素2可以预测丙型肝炎患者的肝血管生成和纤维化程度

2021-03-23

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

GUT：许正平/盛静浩团队发现血管生成素可维持肠道菌群稳态阻止肠炎发生

2020-10-31

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

JCEM：血清血管生成素样蛋白6与2型糖尿病风险

2020-04-15

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

JAK抑制剂Olumiant和抗血管生成素-2单抗LY3127804将用于新冠病毒COVID-19患者临床试验

2020-06-13

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Am J Transl Res：COMP-血管生成素-1对尿毒症腹膜透析大鼠腹膜血管通透性和腹膜转运功能的保护作用

2020-03-04

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Hepatology：血管生成素2是CHC患者接受DAA治疗后，HCC复发或新发的重要预测因素

2018-12-18

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

JCEM：血管生成素样蛋白2促进糖尿病肾病的进展

2018-10-19

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Brit J Cancer：类血管生成素蛋白3能够阻断FAK的细胞核输入并有助于索拉非尼响应

2018-09-13

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Hepatology：HCV直接抗病毒治疗后，血管生成素-2水平增加是肝癌复发和新发肝癌的预测因子

2018-04-27

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Biomed Pharmacother：血管生成素2促进组织工程骨中的血管生成，并通过诱导自噬改善骨缺损的修复

2018-12-29

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Diabetologia：早孕期血管生成素样蛋白8可改善妊娠期糖尿病的预测

2018-12-24

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

JCEM：血管生成素样蛋白3对血浆脂蛋白水平的影响

2018-01-15

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Nat Commun：阻断血管生成素的肿瘤治疗为何效果不一？

2015-02-08

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

Nat Rev Drug Discov：血管生成素抑制剂 trebananib三期临床失败

2015-07-15

xinmeili (审核中...)

前往app查看评论内容

#血管生成素#

EHJ：循环血管生成素增加心源性休克病人死亡风险

2014-02-08

科室
- - 订阅+
  - 更多科室
工具
服务